Cite
HARVARD Citation
Pathan, M. et al. (n.d.). IDF2022-0559 Efficacy and safety of empagliflozin as an add on to metformin and DPP4 inhibitor in T2DM patients, fasting during Ramadan. Diabetes research and clinical practice. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pathan, M. et al. (n.d.). IDF2022-0559 Efficacy and safety of empagliflozin as an add on to metformin and DPP4 inhibitor in T2DM patients, fasting during Ramadan. Diabetes research and clinical practice. p. . [Online].